Cargando…
Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis
The three‐membered RUNX gene family includes RUNX1, a major mutational target in human leukemias, and displays hallmarks of both tumor suppressors and oncogenes. In mouse models, the Runx genes appear to act as conditional oncogenes, as ectopic expression is growth suppressive in normal cells but dr...
Autores principales: | Kilbey, A., Terry, A., Wotton, S., Borland, G., Zhang, Q., Mackay, N., McDonald, A., Bell, M., Wakelam, M.J.O., Cameron, E.R., Neil, J.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408393/ https://www.ncbi.nlm.nih.gov/pubmed/27869314 http://dx.doi.org/10.1002/jcb.25802 |
Ejemplares similares
-
RUNX‐mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins
por: Anderson, Gail, et al.
Publicado: (2017) -
Addiction to RUNX in lymphoma
por: Neil, James C., et al.
Publicado: (2016) -
Addiction to Runx1 is partially attenuated by loss of p53 in the Eμ-Myc lymphoma model
por: Borland, Gillian, et al.
Publicado: (2016) -
Insertional Mutagenesis and Deep Profiling Reveals Gene Hierarchies and a Myc/p53-Dependent Bottleneck in Lymphomagenesis
por: Huser, Camille A., et al.
Publicado: (2014) -
RUNX1 and its fusion oncoprotein derivative RUNX1-ETO induce senescence-like growth arrest independently of replicative stress
por: Wolyniec, Kamil, et al.
Publicado: (2009)